Impact of Children's Auditory Technology

  • Research type

    Research Study

  • Full title

    Impact of Children’s Auditory Technology (iCAT): Audiological, Educational, and Quality of Life Outcomes of Omnidirectional and Adaptive/Directive Hearing Aids and Assistive Listening Devices in 6-to-11 Year Old Children with Mild-to-Moderate Hearing Loss

  • IRAS ID

    360926

  • Contact name

    Hannah J Stewart

  • Contact email

    h.stewart5@lancaster.ac.uk

  • Sponsor organisation

    Lancaster University

  • Duration of Study in the UK

    2 years, 10 months, 30 days

  • Research summary

    Approximately 34 million children worldwide experience disabling hearing loss (WHO, 2025). These children often experience delayed speech and language development. Although many of these children attend mainstream schools in the UK, only 34% achieve two A-levels (or the equivalent), compared to 55% of their hearing peers (NDCS, 2021). Mild-to-moderate hearing loss (MMHL) is the most common hearing impairment in children. However, despite the effect of their hearing impairment on development, it is the least understood form of hearing loss in children. There is an urgent need for research on this understudied group to meet the goal set by the National Deaf Children's Society (the UK's biggest children's hearing charity and a project partner) of making sure that "by 2030, no deaf child will be left behind" (NDCS, 2023).

    Children with MMHL are prescribed AT to assist them. Hearing aids are more advanced and accessible than ever and ALDs - where a talker's speech is streamed directly to the hearing aid to reduce the effects of a noisy background - are now common in classrooms. However, AT is designed based on how adults communicate: adults generally look at the person they are talking with and ask for information to be repeated when they do not hear clearly. On the other hand, children with normal hearing do not look. It is unknown if children with MMHL look at the talker while they listen. This has an impact on the effectiveness of the AT algorithms.

    In this clinical trial, we aim to investigate a variety of approved ATs used in the UK through both the NHS and the Department of Education. These are Oticon Play PX hearing aids with either omnidirectional or adaptive hearing aid algorithms, and Oticon EduMic ALDs.

  • REC name

    East of England - Essex Research Ethics Committee

  • REC reference

    25/EE/0259

  • Date of REC Opinion

    19 Dec 2025

  • REC opinion

    Further Information Favourable Opinion